NCT07008820View on ClinicalTrials.gov

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Myelodysplastic Syndrome (MDS)
Interventions
OTHER

Health-related quality of life questionnaires

"Questionnaires include:~EORTC-QLQ C30 FACT-An PGI-S EQ-5D-5L"

OTHER

Qualitative interviews

For participants that meet eligibility criteria

Trial Locations (1)

1050001

RECRUITING

Local Institution - 0001, Minato-ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT07008820 - Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan | Biotech Hunter | Biotech Hunter